Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation
Sodium glucose cotransporter 2 inhibitors (SGLT2i) are standard of care for type 2 diabetes mellitus, heart failure, and chronic kidney disease (CKD). Heart transplant (HTx) recipients are at increased risk of diabetes and CKD, and both are independently associated with increased mortality. In a ret...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2025-05-01
|
| Reeks: | JHLT Open |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S2950133425000503 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
